Abrozac 100mg/600mg Tablet
Marketer
Ajanta Pharma Ltd
Salt Composition
Acebrophylline (100mg) + Acetylcysteine (600mg)
Overview Abrozac 100mg/600mg Tablet
Combiflam 100mg/600mg tablets are indicated for managing and preventing asthma attacks and the characteristic symptoms of chronic obstructive pulmonary disease (COPD), a lung condition marked by airflow obstruction. These symptoms include coughing fits, wheezing, and breathlessness. The medication facilitates easier breathing by relaxing the airways' muscles. Dosage and treatment duration for Combiflam 100mg/600mg tablets should strictly adhere to your physician's instructions, varying based on individual response and condition severity. Consistent medication use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete transparency regarding all other medications you are currently using is essential, as interactions are possible. Commonly reported side effects include nausea, acid reflux, dyspepsia, skin rashes, pruritus, and rhinitis. Most side effects are transient and self-limiting. However, report any concerns promptly to your doctor. Alcohol consumption should be avoided during treatment to prevent excessive sleepiness. Self-medicating or sharing this medication is strongly discouraged. Prior to commencing treatment, disclose any existing liver or kidney impairments, as well as pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Uses of Abrozac 100mg/600mg Tablet
Managing Asthma, COPD, and Pneumonia
Major Benefits of Abrozac 100mg/600mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Abrozac 100mg/600mg Tablet whole; do not alter its form by chewing, crushing, or breaking. While it can be administered with or without food, consistent timing is recommended for optimal results.
Common Side effects of Abrozac 100mg/600mg Tablet:
- Vomiting
- Heartburn
- Stomach pain
- Upset stomach
- Rash
- Hives
- Itching
- Nasal inflammation
How to use Abrozac 100mg/600mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Abrozac 100mg/600mg Tablets can be ingested with or without food, however, consistent timing is recommended.
How Abrozac 100mg/600mg Tablet works:
Each Abrozac 100mg/600mg tablet unites acebrophylline and acetylcysteine, two medications that ease breathing difficulties. Acebrophylline, a bronchodilator and mucolytic agent, relaxes airway muscles and thins mucus for improved airflow. Similarly, acetylcysteine's mucolytic action liquefies phlegm, facilitating its expulsion through coughing.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Abrozac 100mg/600mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Abrozac 100mg/600mg Tablet usage in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Abrozac 100mg/600mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Abrozac 100mg/600mg tablets.
KidneySAFE IF PRESCRIBED
The use of Abrozac 100mg/600mg tablets in individuals with kidney disease is likely safe. Current evidence indicates dose modification may be unnecessary, but physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Abrozac 100mg/600mg tablets in patients with liver disease appears to be generally safe. Preliminary evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
What if you forget to take Abrozac 100mg/600mg Tablet :
Should you forget to take your Abrozac 100mg/600mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Abrozac 100mg/600mg Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | BREATHING-RELATED |



